» Articles » PMID: 18550180

Comparison of Two-step Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) for Universal Newborn Hearing Screening Programs

Overview
Specialty Pediatrics
Date 2008 Jun 14
PMID 18550180
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Both transitory auditory otoemissions (TEOAE) and automated auditory brainstem responses (AABR) are considered adequate methods for universal hearing screening. The goal of this study was to compare the results obtained with each device, applying the same screening procedure.

Materials And Methods: From 2001 to 2003, all the newborns in our health area (2454 infants) were evaluated with TEOAE (ILO92, otodynamics) and all those born from 2004 to 2006 (3117) were evaluated with AABR (AccuScreen, Fischer-Zoth). The population studied included all well newborns and those admitted to neonatal intensive care units (NICU). The first screening was normally undertaken with well babies during the first 48h of life, before hospital discharge. Infants referred from this first step underwent a second screening after hospital discharge, before they were a month old.

Results: The results from each study group were compared and analyzed for significant differences. TEOAE screening yielded 10.2% fail results from the first screening step; AABR gave 2.6%. In the second screening step, 2% of the newborns screened with TEOAE were referred, whereas 0.32% of those screened with AABR were referred. These differences are statistically significant.

Conclusions: Although AABR screening tests involve a slightly higher cost in time and money than TEOAE, the results obtained compensate this difference. AABR gives fewer false positives and a lower referral rate; the percent of infants lost during follow-up is consequently smaller. Therefore, in our environment, universal newborn auditory screening with AABR is more effective than that with TEOAE.

Citing Articles

Referral rate and false-positive rates in a hearing screening program among high-risk newborns.

Thangavelu K, Martakis K, Feldmann S, Roth B, Lang-Roth R Eur Arch Otorhinolaryngol. 2023; 280(10):4455-4465.

PMID: 37154942 PMC: 10477105. DOI: 10.1007/s00405-023-07978-y.


Universal Newborn Hearing Screening: An Indian Experience of Conceptualizing and Testing a Comprehensive Model.

Ravi R, Gunjawate D, Yerraguntla K, Bellur R Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 1):170-177.

PMID: 36032924 PMC: 9411350. DOI: 10.1007/s12070-020-01937-3.


The Hearing Status of Preterm Infant's ≤ 34 Weeks as Revealed by Otoacoustic Emissions (OAE) Screening and Diagnostic Brainstem Evoked Response Audiometry (BERA): A Tertiary Center Experience.

Gulati A, Sakthivel P, Singh I, Ramji S Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 1):178-183.

PMID: 36032856 PMC: 9411318. DOI: 10.1007/s12070-020-01945-3.


Protocol and programme factors associated with referral and loss to follow-up from newborn hearing screening: a systematic review.

Mackey A, Busse A, Del Vecchio V, Maki-Torkko E, Uhlen I BMC Pediatr. 2022; 22(1):473.

PMID: 35932008 PMC: 9354382. DOI: 10.1186/s12887-022-03218-0.


Neonatal Hearing Screening, with Otoacoustic Emission, among Normal Babies in a Northeastern Nigerian Hospital.

Abdullahi A, Shofoluwe N, Abubakar A, Sandabe M, Garandawa H, Babatunde M J West Afr Coll Surg. 2022; 11(1):11-14.

PMID: 35873873 PMC: 9302393. DOI: 10.4103/jwas.jwas_32_22.